Koneko Research

Koneko Research

Management Buyout With 43% Arb Return

Koneko Research's avatar
Koneko Research
Jun 02, 2026
∙ Paid

This Pink Sheets issuer has a very low investor profile and I have seen zero commentary about the arbitrage opportunity. The company anticipates closing its privatization in 4Q26 and I believe the transaction is highly likely to be completed:

  • Hot sector experiencing rapid growth

  • Blue chip customer relationships

  • CEO’s privatization offer is fully funded with strong financial and strategic partner backing

Complexities:

  • Limited liquidity - turnover of $20k/day

  • Pink Sheets listing not tradeable through some brokers

  • Company is losing money

  • High downside (possibly >75%) if the deal fails to close

Due to the limited liquidity and high downside risk I am not putting the issuer name in the preview. I don’t think anybody should buy this without being comfortable with the full story.

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2026 Koneko Research · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture